Last €52.02 EUR
Change Today -1.30 / -2.44%
Volume 1.7K
DSM2 On Other Exchanges
EN Amsterdam
As of 11:30 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

koninklijke dsm nv (DSM2) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/19/13 - €60.08
52 Week Low
02/27/14 - €45.67
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KONINKLIJKE DSM NV (DSM2)

Related News

No related news articles were found.

koninklijke dsm nv (DSM2) Related Businessweek News

View More BusinessWeek News

koninklijke dsm nv (DSM2) Details

Koninklijke DSM N.V. operates as a life sciences and materials sciences company worldwide. The company operates in five segments: Nutrition, Pharma, Performance Materials, Polymer Intermediates, and Innovation Center. It manufactures food enzymes, cultures, savory ingredients, and other specialties, as well as nutritional products, such as vitamins, carotenoids, eubiotics, feed enzymes, premixes, nutritional lipids, and cultures for the food and beverage, feed, personal care, dietary supplements, and pharmaceutical industries. The company also provides custom manufacturing and development services to the pharmaceutical, biopharmaceutical, and agrochemical industries; and beta-lactam active pharmaceutical ingredients, such as semi-synthetic penicillins and semi-synthetic cephalosporins, as well as nystatin. In addition, it offers engineering thermoplastic solutions; Dyneema, a strong fiber; and resins solutions for paints and coatings, composite materials, and optical fiber coatings. Further, the company produces caprolactam and acrylonitrile that are raw materials for synthetic fibers and plastics; and other products, including ammonium sulfate, sodium cyanide, cyclohexanone, and diaminobutane. Additionally, it develops materials-based solutions comprising coatings, drug delivery platforms, and a range of biomedical materials for medical device and biopharmaceutical industries; creates solutions for bioconversion of feedstocks for the production of bio-energy, such as cellulosic biofuels, as well as bio-based chemicals and materials; and provides smart coatings and surface technologies to the solar industry. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

21,189 Employees
Last Reported Date: 05/6/14
Founded in 1902

koninklijke dsm nv (DSM2) Top Compensated Officers

Chairman of Managing Board, Chief Executive O...
Total Annual Compensation: €1.4M
Chief Financial Officer and Member of the Man...
Total Annual Compensation: €902.0K
Member of The Managing Board
Total Annual Compensation: €954.0K
Member of Managing Board
Total Annual Compensation: €887.0K
Member of The Managing Board
Total Annual Compensation: €268.0K
Compensation as of Fiscal Year 2013.

koninklijke dsm nv (DSM2) Key Developments

Koninklijke DSM N.V. Presents at The Nomura European SRI Conference, Jun-26-2014

Koninklijke DSM N.V. Presents at The Nomura European SRI Conference, Jun-26-2014 . Venue: London, United Kingdom. Speakers: Fokko Wientjes, Director Sustainability, Marc Silvertand, IR Manager.

DSM Opens New Animal Nutrition Center

DSM has announced the opening of its China Animal Nutrition Center in the Chinese town of Bazhou, south of Beijing. With its focus on swine and poultry nutrition and the capabilities to conduct world-class scientific and application research, the facility will support the development of tailored solutions to meet the needs of the fast growing poultry and swine markets in China. The country's animal nutrition market is fast expanding as livestock production matures and becomes more industrialized. With a special focus on enzymes, eubiotics and vitamins, the new research facility will support ongoing market development by enabling the application of DSM products to address the needs of local swine and poultry producers, further enhancing customer relations in the region. It will also produce scientific data to support product and application development for use in global markets.

DSM Presents at World Congress on Industrial Biotechnology, May-12-2014

DSM Presents at World Congress on Industrial Biotechnology, May-12-2014 . Venue: Philadelphia, Pennsylvania, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DSM2:GR €52.02 EUR -1.30

DSM2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Agrium Inc C$99.68 CAD +0.77
Grupo Bimbo SAB de CV $41.80 MXN +0.24
Kerry Group PLC €56.95 EUR +0.20
Merck KGaA €64.27 EUR -0.95
Solvay SA €126.15 EUR -1.75
View Industry Companies

Industry Analysis


Industry Average

Valuation DSM2 Industry Range
Price/Earnings 47.5x
Price/Sales 1.0x
Price/Book 1.5x
Price/Cash Flow 38.4x
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KONINKLIJKE DSM NV, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at